Michael Gelband’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Michael Gelband’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-17,246	Closed	-$62K	–	2836
2021 Q3	$62K	Sell	17,246 -3,464	-17%	-$13.1K	﹤0.01%	1957
2021 Q2	$74K	Sell	20,710 -18,600	-47%	-$65.6K	﹤0.01%	2190
2021 Q1	$154K	Buy	+39,310	New	+$162K	﹤0.01%	1918
2020 Q3	–	Sell	-21,801	Closed	-$95K	–	2458
2020 Q2	$95K	Sell	21,801 -7,516	-26%	-$33.8K	﹤0.01%	1640
2020 Q1	$111K	Sell	29,317 -56,348	-66%	-$277K	0.01%	881
2019 Q4	$541K	Buy	+85,665	New	+$504K	0.01%	816
2019 Q2	–	Sell	-165,590	Closed	-$878K	–	1456
2019 Q1	$878K	Buy	165,590 +101,283	+157%	+$463K	0.07%	211
2018 Q4	$238K	Buy	+64,307	New	+$226K	0.02%	235

Other funds holding BDSI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Michael Gelband's BDSI Position: Q4 2021 in Review

Michael Gelband sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2021, closing a stake of 17,246 shares — an estimated $62K sold.

Michael Gelband first reported a position in BDSI in Q4 2018 and held it in 8 quarters. The position peaked at $878K in Q1 2019. 156 funds tracked by Wall St. Rank hold BDSI as of Q4 2021.

Michael Gelband reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2021 after selling out during the quarter.
Michael Gelband sold 17,246 BioDelivery Sciences International, Inc. shares in Q4 2021, an estimated $62K.
Michael Gelband first reported a position in BioDelivery Sciences International, Inc. in Q4 2018 and held it in 8 quarters.
Michael Gelband's BioDelivery Sciences International, Inc. position peaked at $878K in Q1 2019.
156 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2021.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.